Achilles detachment in rat and stable gastric pentadecapeptide BPC 157: Promoted tendon-to-bone healing and opposed corticosteroid aggravation.
Level 5 - mechanism / opinion, no new human data
Preclinical animal interventional study.
PubMed 16583442 · doi:10.1002/jor.20096
What was done
Rats underwent surgical sharp transection of the Achilles tendon from the calcaneal bone. Animals received daily intraperitoneal injections of BPC 157 (10 µg, 10 ng, or 10 pg/kg), 6alpha-methylprednisolone (1 mg/kg), saline control (0.9% NaCl, 5 mL/kg), or combinations thereof, starting 30 minutes post-surgery. Outcomes were evaluated at days 1, 4, 7, 10, 14, and 21 post-injury via the Achilles functional index (AFI), biomechanical testing (load to failure, stiffness, Young's modulus), histology, and immunohistochemistry.
What was found
The abstract reports no exact numeric values or statistical measures. Qualitatively, BPC 157 treatment was reported to increase AFI scores, significantly improve biomechanical parameters (load to failure, stiffness, and Young elasticity modulus), promote vascularity and type I collagen organization, and counteract healing impairment caused by 6alpha-methylprednisolone.
Why it matters
This animal study suggests BPC 157 may promote direct tendon-to-bone reattachment and offset corticosteroid-related tissue damage in a rodent model. However, human clinical evidence is required to establish therapeutic efficacy and safety.
Limits
The study is limited to a rodent model, meaning findings cannot be directly extrapolated to human tendon-to-bone healing. The abstract omits sample sizes (n), specific quantitative data, effect sizes, and variance estimates.
Cited by
- supports BPC-157 administration counteracts corticosteroid-induced impairment of wound healing in animal models.